| UniProt ID | ANKS3_HUMAN | |
|---|---|---|
| UniProt AC | Q6ZW76 | |
| Protein Name | Ankyrin repeat and SAM domain-containing protein 3 | |
| Gene Name | ANKS3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 656 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MSELSDEASEPELLNRSLSMWHGLGTQVSGEELDVPLDLHTAASIGQYEVVKECVQRRELDLNKKNGGGWTPLMYASYIGHDTIVHLLLEAGVSVNVPTPEGQTPLMLASSCGNESIAYFLLQQGAELEMKDIQGWTALFHCTSAGHQHMVRFLLDSGANANVREPICGFTPLMEAAAAGHEIIVQYFLNHGVKVDARDHSGATARMLAKQYGHMKIVALMDTYSPSLPKSLYRSPEKYEDLSSSDESCPAPQRQRPCRKKGVSIHEGPRALARITGIGLGGRAPRPRYEQAPPRGYVTFNSSGENPLEEEGLCCRDVTSPINERDVESSSSSSSREEHAFCANLGPVQSSSSSEGLARAQGLSSEASVESNEDSDHACKSSARKQAKSYMKTKNPDSQWPPRAATDREGFLAESSPQTQRAPYSGPQDLAALLEQIGCLKYLQVFEEQDVDLRIFLTLTESDLKEIGITLFGPKRKMTSAIARWHSSARPPGDALELAYADRLEAEMQELAIQLHKRCEEVEATRGQVCQEQELRAVVESCLLEQDRAREDLQARLRETWALARDAALVLDQLRACQAELSSRVRQDQPPGAATLGLAVPPADSKGWQASLQAMSLPELSGALEDRVREMGQALCLVTQSLEKLQVLNGKKWRET | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSELSDEAS ------CCCCCHHHC | 47.44 | 25159151 | |
| 5 | Phosphorylation | ---MSELSDEASEPE ---CCCCCHHHCCHH | 29.38 | 25159151 | |
| 9 | Phosphorylation | SELSDEASEPELLNR CCCCHHHCCHHHHHH | 52.19 | 25159151 | |
| 96 | Hydroxylation | LEAGVSVNVPTPEGQ HHCCCEEECCCCCCC | 26.92 | - | |
| 201 | Phosphorylation | KVDARDHSGATARML CCCCCCCCHHHHHHH | 34.12 | - | |
| 212 | Phosphorylation | ARMLAKQYGHMKIVA HHHHHHHHCCEEEEE | 14.32 | 22817900 | |
| 223 | Phosphorylation | KIVALMDTYSPSLPK EEEEEHHCCCCCCCH | 16.37 | 25850435 | |
| 224 | Phosphorylation | IVALMDTYSPSLPKS EEEEHHCCCCCCCHH | 17.83 | 25850435 | |
| 225 | Phosphorylation | VALMDTYSPSLPKSL EEEHHCCCCCCCHHH | 15.31 | 25159151 | |
| 227 | Phosphorylation | LMDTYSPSLPKSLYR EHHCCCCCCCHHHCC | 51.90 | 25850435 | |
| 233 | Phosphorylation | PSLPKSLYRSPEKYE CCCCHHHCCCHHHHH | 19.01 | 22817900 | |
| 235 | Phosphorylation | LPKSLYRSPEKYEDL CCHHHCCCHHHHHCC | 24.69 | 63779713 | |
| 239 | Phosphorylation | LYRSPEKYEDLSSSD HCCCHHHHHCCCCCC | 17.02 | 27732954 | |
| 243 | Phosphorylation | PEKYEDLSSSDESCP HHHHHCCCCCCCCCC | 39.87 | 20363803 | |
| 244 | Phosphorylation | EKYEDLSSSDESCPA HHHHCCCCCCCCCCC | 49.45 | 20363803 | |
| 245 | Phosphorylation | KYEDLSSSDESCPAP HHHCCCCCCCCCCCC | 41.86 | 20363803 | |
| 248 | Phosphorylation | DLSSSDESCPAPQRQ CCCCCCCCCCCCCCC | 30.32 | 27732954 | |
| 264 | Phosphorylation | PCRKKGVSIHEGPRA CCCCCCCCCCCCHHH | 27.22 | 19531433 | |
| 276 | Phosphorylation | PRALARITGIGLGGR HHHHHHHHCCCCCCC | 19.73 | 28555341 | |
| 302 | Phosphorylation | RGYVTFNSSGENPLE CCEEEECCCCCCCCC | 35.21 | 23663014 | |
| 303 | Phosphorylation | GYVTFNSSGENPLEE CEEEECCCCCCCCCC | 51.75 | 23663014 | |
| 319 | Phosphorylation | GLCCRDVTSPINERD CCEECCCCCCCCHHH | 32.83 | 30266825 | |
| 320 | Phosphorylation | LCCRDVTSPINERDV CEECCCCCCCCHHHC | 24.51 | 16964243 | |
| 364 | Phosphorylation | LARAQGLSSEASVES HHHHCCCCCHHHCCC | 32.72 | 23663014 | |
| 365 | Phosphorylation | ARAQGLSSEASVESN HHHCCCCCHHHCCCC | 42.07 | 23663014 | |
| 368 | Phosphorylation | QGLSSEASVESNEDS CCCCCHHHCCCCCCC | 23.51 | 23663014 | |
| 371 | Phosphorylation | SSEASVESNEDSDHA CCHHHCCCCCCCCCH | 43.28 | 23663014 | |
| 375 | Phosphorylation | SVESNEDSDHACKSS HCCCCCCCCCHHHHH | 25.72 | 23663014 | |
| 381 | Phosphorylation | DSDHACKSSARKQAK CCCCHHHHHHHHHHH | 29.16 | 28857561 | |
| 382 | Phosphorylation | SDHACKSSARKQAKS CCCHHHHHHHHHHHH | 20.00 | 28857561 | |
| 415 | Phosphorylation | REGFLAESSPQTQRA CCCCCCCCCCCCCCC | 41.53 | 23663014 | |
| 416 | Phosphorylation | EGFLAESSPQTQRAP CCCCCCCCCCCCCCC | 16.72 | 25159151 | |
| 419 | Phosphorylation | LAESSPQTQRAPYSG CCCCCCCCCCCCCCC | 24.33 | 23663014 | |
| 541 | Phosphorylation | ELRAVVESCLLEQDR HHHHHHHHHHHHCHH | 9.84 | 50565653 | |
| 651 | Ubiquitination | KLQVLNGKKWRET-- HHHHHCCCCCCCC-- | 48.35 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ANKS3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 5 | S | Phosphorylation |
| - |
| 96 | N | Hydroxylation |
| - |
| 225 | S | Phosphorylation |
| - |
| 319 | T | Phosphorylation |
| - |
| 320 | S | Phosphorylation |
| - |
| 368 | S | Phosphorylation |
| - |
| 371 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ANKS3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ANKS6_HUMAN | ANKS6 | physical | 27173435 | |
| NEK7_HUMAN | NEK7 | physical | 27173435 | |
| NEK8_HUMAN | NEK8 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-5 AND SER-9, ANDMASS SPECTROMETRY. | |